Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms

(2018) Daniele Cattaneo et al.   European Journal of Internal Medicine

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients

(2018) Ayalew Tefferi et al.   LEUKEMIA

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

(2018) Tiziano Barbui et al.   LEUKEMIA

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms

(2018) Valerio De Stefano et al.   Blood Cancer Journal

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

(2018) Tiziano Barbui et al.   Blood Cancer Journal

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

(2018) Valerio De Stefano et al.   Blood Cancer Journal

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists

(2016) V De Stefano et al.   LEUKEMIA

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment

(2016) Silvia Betti et al.   THROMBOSIS AND HAEMOSTASIS

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients

(2016) V De Stefano et al.   Blood Cancer Journal

Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia

(2015) Juan-Carlos Hernández-Boluda et al.   ANNALS OF HEMATOLOGY

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

(2015) N. Riva et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis

(2015) Umberto Gianelli et al.   LEUKEMIA RESEARCH

Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosis

(2015) Suleyman Karakose et al.   Turkish Journal of Gastroenterology

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms An European Leukemia Net study

(2014) Ida Martinelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Myeloproliferative neoplasms and thrombosis

(2013) T. Barbui et al.   BLOOD

Splanchnic vein thrombosis in myeloproliferative neoplasms

(2013) Mallika Sekhar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper

(2013) Giovanni Barosi et al.   LEUKEMIA RESEARCH

Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: A role for the JAK2 V617F mutation re-evaluation

(2013) Donatella Colaizzo et al.   THROMBOSIS RESEARCH

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

(2012) J. H. Smalberg et al.   BLOOD

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Cerebral sinus-venous thrombosis

(2012) Ida Martinelli et al.   Internal and Emergency Medicine

Clinical approach to splanchnic vein thrombosis: Risk factors and treatment

(2012) Nicoletta Riva et al.   THROMBOSIS RESEARCH

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms

(2011) J. HOEKSTRA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Splanchnic vein thrombosis: clinical presentation, risk factors and treatment

(2010) Valerio De Stefano et al.   Internal and Emergency Medicine

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA